Merger Notification - Announcement according to § 10 Cartel Act

OneMed Holding AB; Diashop GmbH; EvivaMed Handelsgesellschaft mbH; Med4Trade GmbH; EvivaMed Distribution GmbH - BWB/Z-5186 | Bundeswettbewerbsbehörde

OneMed Holding AB; Diashop GmbH; EvivaMed Handelsgesellschaft mbH; Med4Trade GmbH; EvivaMed Distribution GmbH

BWB/Z-5186

07.01.2021

On 07.01.2021 the Austrian Federal Competition Authority was notified of the following merger:

Planned purchase process

OneMed Holding AB (Danderyd, Sweden), a holding company ultimately (indirectly) controlled by Interogo Foundation (Vaduz, Liechtenstein), intends to acquire from BBM Beratungs- und Beteiligungsgesellschaft für Medizintechnik mbH (Herrsching, Germany) 60% of the shares in and sole control of DIASHOP GmbH (Germering, Germany) as well as from EvivaMed Verwaltungs- und Beteiligungsgesellschaft mbH (Herrsching, Germany) 60% of the shares in and sole control of EvivaMed Handelsgesellschaft mbH (Wenzenbach, Germany), Med4Trade GmbH (Wenzenbach, Germany) and EvivaMed Distribution GmbH (Herrsching am Ammersee, Germany).

The notified concentration concerns the distribution of medical supplies and non-pharmacy drugs.

Industry sector: G - Handel; Instandhaltung und Reparatur von Kraftfahrzeugen

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 04.02.2021.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 05.02.2021 .

back to list